The FDA approved Signifier’s request to remove certain contraindications for its daytime sleep apnea therapy device, a “milestone” approval Signifier says will allow greater patient reach.
Read More
Bioscience Association Manitoba unveiled four winners, including Cerebra, to be honored at its Annual Awards Dinner on March 2. Here’s which award Cerebra is picking up.
Read More
Axsome Therapeutics discusses what’s next for Sunosi, used to reduce excessive daytime sleepiness in adults with narcolepsy or sleep apnea, and AXS-12, a narcolepsy drug candidate in clinical trials.
Read More
Investigators explore the role genes might play in sleep apnea, illuminating the underlying biology of the condition and pointing to possible therapeutic options.
Read More
Harmony Biosciences spelled out next steps in its pursuit of pediatric exclusivity for WAKIX.
Read More